
Multiple Sclerosis Clinical Trial Pipeline Shows Potential With Active Contributions From 60+ Key Companies ...
(MENAFN- GlobeNewsWire - Nasdaq) Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is driving significant …